Beyond pattern recognition: NOD-like receptors in dendritic cells

Trends in Immunology

Volumn 34, Issue 5, 2013, Pages 224-233

  Krishnaswamy, Jayendra Kumar ^a   Chu, Thach ^a   Eisenbarth, Stephanie C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; INTERLEUKIN 1BETA; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR;

ADAPTIVE IMMUNITY; AUTOPHAGY; CELL MIGRATION; DENDRITIC CELL; IMMUNE SYSTEM; INNATE IMMUNITY; PATTERN RECOGNITION; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE;

ADAPTIVE IMMUNITY; ANIMALS; DENDRITIC CELLS; HUMANS; IMMUNITY, INNATE; LYMPHOCYTE ACTIVATION; NOD SIGNALING ADAPTOR PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PATTERN RECOGNITION; T-LYMPHOCYTES;

EID: 84877102781     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2012.12.003     Document Type: Review

References (123)

1. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
2. Strowig T., et al. Inflammasomes in health and disease. Nature 2012, 481:278-286.
3. Palm N.W., Medzhitov R. Pattern recognition receptors and control of adaptive immunity. Immunol. Rev. 2009, 227:221-233.
4. Kemper C., Atkinson J.P. T-cell regulation: with complements from innate immunity. Nat. Rev. Immunol. 2007, 7:9-18.
5. van den Berg T.K., van der Schoot C.E. Innate immune 'self' recognition: a role for CD47-SIRPalpha interactions in hematopoietic stem cell transplantation. Trends Immunol. 2008, 29:203-206.
6. Deban L., et al. Pentraxins in innate immunity: lessons from PTX3. Cell Tissue Res. 2011, 343:237-249.
7. Rajalingam R. Overview of the killer cell immunoglobulin-like receptor system. Methods Mol. Biol. 2012, 882:391-414.
8. Piccinini A.M., Midwood K.S. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010, 2010. Article ID 672395. 10.1155/2010/672395.
9. Ahrens S., et al. F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells. Immunity 2012, 36:635-645.
10. Acton S.E., et al. Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2. Immunity 2012, 37:276-289.
11. Ramos H.J., Gale M. RIG-I like receptors and their signaling crosstalk in the regulation of antiviral immunity. Curr. Opin. Virol. 2011, 1:167-176.
12. Schattgen S.A., Fitzgerald K.A. The PYHIN protein family as mediators of host defenses. Immunol. Rev. 2011, 243:109-118.
13. Kofoed E.M., Vance R.E. Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature 2011, 477:592-595.
14. Khare S., et al. An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages. Immunity 2012, 36:464-476.
15. Lightfield K.L., et al. Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin. Nat. Immunol. 2008, 9:1171-1178.
16. Ichinohe T., et al. Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat. Immunol. 2010, 11:404-410.
17. Nour A.M., et al. Anthrax lethal toxin triggers the formation of a membrane-associated inflammasome complex in murine macrophages. Infect. Immun. 2009, 77:1262-1271.
18. Wickliffe K.E., et al. Anthrax lethal toxin-induced inflammasome formation and caspase-1 activation are late events dependent on ion fluxes and the proteasome. Cell. Microbiol. 2008, 10:332-343.
19. Sutterwala F.S., et al. Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J. Exp. Med. 2007, 204:3235-3245.
20. Miao E.A., et al. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:3076-3080.
21. Hornung V., et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 2008, 9:847-856.
22. Williams A., et al. The role of NOD-like receptors in shaping adaptive immunity. Curr. Opin. Immunol. 2010, 22:34-40.
23. Allen I.C., et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 2009, 30:556-565.
24. Joly S., et al. Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome. J. Immunol. 2009, 183:3578-3581.
25. Lamkanfi M., et al. Fungal zymosan and mannan activate the cryopyrin inflammasome. J. Biol. Chem. 2009, 284:20574-20581.
26. Lightfield K.L., et al. Differential requirements for NAIP5 in activation of the NLRC4 inflammasome. Infect. Immun. 2011, 79:1606-1614.
27. Girardin S.E., et al. Identification of the critical residues involved in peptidoglycan detection by Nod1. J. Biol. Chem. 2005, 280:38648-38656.
28. Mo J., et al. Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP. J. Biol. Chem. 2012, 287:23057-23067.
29. Tanabe T., et al. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J. 2004, 23:1587-1597.
30. Tschopp J. Mitochondria: sovereign of inflammation?. Eur. J. Immunol. 2011, 41:1196-1202.
31. Ciraci C., et al. Control of innate and adaptive immunity by the inflammasome. Microbes Infect. 2012, 14:1263-1270.
32. Juliana C., et al. Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation. J. Biol. Chem. 2012, 287:36617-36622.
33. Lu B., et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature 2012, 488:670-674.
34. Hornung V., Latz E. Critical functions of priming and lysosomal damage for NLRP3 activation. Eur. J. Immunol. 2010, 40:620-623.
35. Iyer S.S., et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:20388-20393.
36. Krysko D.V., et al. Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol. 2011, 32:157-164.
37. Nakahira K., et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 2011, 12:222-230.
38. Shimada K., et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 2012, 36:401-414.
39. Zhou R., et al. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469:221-225.
40. Dangl J.L., Jones J.D. Plant pathogens and integrated defence responses to infection. Nature 2001, 411:826-833.
41. Steinman R., Inaba K. Immunogenicity: role of dendritic cells. Bioessays 1989, 10:145-152.
42. Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 1989, 54:1-13.
43. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004, 5:987-995.
44. Randolph G.J., et al. Migration of dendritic cell subsets and their precursors. Annu. Rev. Immunol. 2008, 26:293-316.
45. Schwarz, H. et al. (2012) TLR8 and NOD signaling synergistically induce the production of IL-1b and IL-23 in monocyte-derived DCs and enhance the expression of the feedback inhibitor SOCS2. Immunobiology (in press).
46. Fritz J.H., et al. Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 2007, 26:445-459.
47. Inohara N., et al. An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 2000, 275:27823-27831.
48. Lautz K., et al. NLRP10 enhances Shigella-induced pro-inflammatory responses. Cell. Microbiol. 2012, 14:1568-1583.
49. Fritz J.H., et al. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists. Eur. J. Immunol. 2005, 35:2459-2470.
50. Magalhaes J.G., et al. Essential role of Rip2 in the modulation of innate and adaptive immunity triggered by Nod1 and Nod2 ligands. Eur. J. Immunol. 2011, 41:1445-1455.
51. Magalhaes J.G., et al. Nucleotide oligomerization domain-containing proteins instruct T cell helper type 2 immunity through stromal activation. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:14896-14901.
52. Asano J., et al. Nucleotide oligomerization binding domain-like receptor signaling enhances dendritic cell-mediated cross-priming in vivo. J. Immunol. 2010, 184:736-745.
53. Wagner C.S., Cresswell P. TLR and nucleotide-binding oligomerization domain-like receptor signals differentially regulate exogenous antigen presentation. J. Immunol. 2012, 188:686-693.
54. Ting J.P.Y., et al. How the noninflammasome NLRs function in the innate immune system. Science 2010, 327:286-290.
55. Schneider M., et al. The innate immune sensor NLRC3 attenuates Toll-like receptor signaling via modification of the signaling adaptor TRAF6 and transcription factor NF-κB. Nat. Immunol. 2012, 13:823-831.
56. Zaki M.H., et al. The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer Cell 2011, 20:649-660.
57. Williams K.L., et al. The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals. J. Biol. Chem. 2005, 280:39914-39924.
58. Lich J.D., et al. Monarch-1 suppresses non-canonical NF-kappaB activation and p52-dependent chemokine expression in monocytes. J. Immunol. 2007, 178:1256-1260.
59. Arthur J.C., et al. Heat shock protein 90 associates with monarch-1 and regulates its ability to promote degradation of NF-kappaB-inducing kinase. J. Immunol. 2007, 179:6291-6296.
60. Fiorentino L., et al. A novel PAAD-containing protein that modulates NF-kappa B induction by cytokines tumor necrosis factor-alpha and interleukin-1beta. J. Biol. Chem. 2002, 277:35333-35340.
61. Fontalba A., et al. NLRP2, an inhibitor of the NF-kappaB pathway, is transcriptionally activated by NF-kappaB and exhibits a nonfunctional allelic variant. J. Immunol. 2007, 179:8519-8524.
62. Elinav E., et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145:745-757.
63. Anand P.K., et al. NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens. Nature 2012, 488:389-393.
64. Tattoli I., et al. NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kappaB and JNK pathways by inducing reactive oxygen species production. EMBO Rep. 2008, 9:293-300.
65. Moore C.B., et al. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 2008, 451:573-577.
66. Xia X., et al. NLRX1 negatively regulates TLR-induced NF-κB signaling by targeting TRAF6 and IKK. Immunity 2011, 34:843-853.
67. Bauernfeind F.G., et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 2009, 183:787-791.
68. LeibundGut-Landmann S., et al. Specificity and expression of CIITA, the master regulator of MHC class II genes. Eur. J. Immunol. 2004, 34:1513-1525.
69. Nickerson K., et al. Dendritic cell-specific MHC class II transactivator contains a caspase recruitment domain that confers potent transactivation activity. J. Biol. Chem. 2001, 276:19089-19093.
70. LeibundGut-Landmann S., et al. MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells. Nat. Immunol. 2004, 5:899-908.
71. Biswas A., et al. Cutting edge: impaired MHC class I expression in mice deficient for nlrc5/class I transactivator. J. Immunol. 2012, 189:516-520.
72. Neerincx A., et al. NLRC5 controls basal MHC class I gene expression in an MHC enhanceosome-dependent manner. J. Immunol. 2012, 188:4940-4950.
73. Staehli F., et al. NLRC5 deficiency selectively impairs MHC class I- dependent lymphocyte killing by cytotoxic T cells. J. Immunol. 2012, 188:3820-3828.
74. Eisenbarth S.C., et al. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008, 453:1122-1126.
75. Watanabe H., et al. Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J. Invest. Dermatol. 2007, 127:1956-1963.
76. Ghiringhelli F., et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat. Med. 2009, 15:1170-1178.
77. Li H., et al. Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J. Immunol. 2008, 181:17-21.
78. Allen I.C., et al. Analysis of NLRP3 in the development of allergic airway disease in mice. J. Immunol. 2012, 188:2884-2893.
79. McKee A.S., et al. Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J. Immunol. 2009, 183:4403-4414.
80. Thomas P.G., et al. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 2009, 30:566-575.
81. Franchi L., Núñez G. The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity. Eur. J. Immunol. 2008, 38:2085-2089.
82. Kool M., et al. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J. Immunol. 2008, 181:3755-3759.
83. Kool M., et al. An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma. Immunity 2011, 34:527-540.
84. Inoue M., et al. NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:10480-10485.
85. Gris D., et al. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J. Immunol. 2010, 185:974-981.
86. Shaw P.J., et al. Cutting edge: critical role for PYCARD/ASC in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2010, 184:4610-4614.
87. Ichinohe T., et al. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 2009, 206:79-87.
88. Sallusto F., et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 1998, 28:2760-2769.
89. Ohl L., et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 2004, 21:279-288.
90. Eisenbarth S.C., et al. NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells. Nature 2012, 484:510-513.
91. Li J., et al. Caspase-11 regulates cell migration by promoting Aip1-Cofilin-mediated actin depolymerization. Nat. Cell Biol. 2007, 9:276-286.
92. Ippagunta S.K., et al. The inflammasome adaptor ASC regulates the function of adaptive immune cells by controlling Dock2-mediated Rac activation and actin polymerization. Nat. Immunol. 2011, 12:1010-1016.
93. Ippagunta S.K., et al. Addendum: defective Dock2 expression in a subset of ASC-deficient mouse lines. Nat. Immunol. 2012, 13:701-702.
94. Arthur J.C., et al. Cutting edge: NLRP12 controls dendritic and myeloid cell migration to affect contact hypersensitivity. J. Immunol. 2010, 185:4515-4519.
95. Allen I.C., et al. Characterization of NLRP12 during the development of allergic airway disease in mice. PLoS ONE 2012, 7:e30612.
96. Eisenbarth S.C., et al. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 2002, 196:1645-1651.
97. Schnare M., et al. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2001, 2:947-950.
98. Krishnaswamy J.K., et al. Toll-like receptor-2 agonist-allergen coupling efficiently redirects th2 cell responses and inhibits allergic airway eosinophilia. Am. J. Respir. Cell Mol. Biol. 2012, 47:852-863.
99. Bretscher P.A. A two-step, two-signal model for the primary activation of precursor helper T cells. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:185-190.
100. Knudson A.G. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. U.S.A. 1971, 68:820-823.
101. Eisenbarth G.S. Type 1 Diabetes: Molecular, Cellular and Clinical Immunology 2004, Kluwer Academic/Plenum. 2nd edn.
102. Nish S., Medzhitov R. Host defense pathways: role of redundancy and compensation in infectious disease phenotypes. Immunity 2011, 34:629-636.
103. Garaude J., et al. Simultaneous targeting of toll- and nod-like receptors induces effective tumor-specific immune responses. Sci. Transl. Med. 2012, 4:120ra116.
104. Trinchieri G., Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 2007, 7:179-190.
105. Kufer T.A., Sansonetti P.J. Sensing of bacteria: NOD a lonely job. Curr. Opin. Microbiol. 2007, 10:62-69.
106. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 1994, 12:991-1045.
107. Medzhitov R. Approaching the asymptote: 20 years later. Immunity 2009, 30:766-775.
108. Karre K., et al. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986, 319:675-678.
109. Lee S.J., et al. The IFN-gamma-induced transcriptional program of the CIITA gene is inhibited by statins. Eur. J. Immunol. 2008, 38:2325-2336.
110. Pashenkov M.V., et al. Muropeptides trigger distinct activation profiles in macrophages and dendritic cells. Int. Immunopharmacol. 2010, 10:875-882.
111. Franchi L., et al. Sensing and reacting to microbes through the inflammasomes. Nat. Immunol. 2012, 13:325-332.
112. Levinsohn J.L., et al. Anthrax lethal factor cleavage of Nlrp1 is required for activation of the inflammasome. PLoS Pathog. 2012, 8:e1002638.
113. Vladimer G.I., et al. The NLRP12 inflammasome recognizes Yersinia pestis. Immunity 2012, 37:96-107.
114. Bruey J.M., et al. PAN1/NALP2/PYPAF2, an inducible inflammatory mediator that regulates NF-kappaB and caspase-1 activation in macrophages. J. Biol. Chem. 2004, 279:51897-51907.
115. Cui J., et al. NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4. Nat. Immunol. 2012, 13:387-395.
116. Ting J.P., et al. The NLR gene family: a standard nomenclature. Immunity 2008, 28:285-287.
117. Origin of Eukaryotic Cells: Evidence and Research Implications for a Theory of the Origin and Evolution of Microbial, Plant, and Animal Cells on the Precambrian Earth 1970, Yale University Press. L. Margulis (Ed.).
118. Riedl S.J., Salvesen G.S. The apoptosome: signalling platform of cell death. Nat. Rev. Mol. Cell Biol. 2007, 8:405-413.
119. Lee H.K., et al. In vivo requirement for Atg5 in antigen presentation by dendritic cells. Immunity 2010, 32:227-239.
120. Travassos L.H., et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol. 2010, 11:55-62.
121. Cooney R., et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat. Med. 2010, 16:90-97.
122. Jounai N., et al. NLRP4 negatively regulates autophagic processes through an association with beclin1. J. Immunol. 2011, 186:1646-1655.
123. Turley S.J., et al. The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs. Nat. Rev. Immunol. 2010, 10:813-825.